BIOCAPTIVA LIMITED

BIOCAPTIVA LIMITED is a leading biotechnology company dedicated to revolutionizing liquid biopsy and nucleic acid (NA) extraction. Harnessing proprietary msX™ polymer technology, BIOCAPTIVA is addressing critical challenges in the liquid biopsy market, empowering breakthroughs in genetic disease detection, diagnosis, monitoring, and treatment. The company's advanced extraction method ensures unparalleled cell-free NA yield and quality, driving progress in precision medicine and multi-omics research.

BIOCAPTIVA's innovative, biocompatible NA-binding polymers offer unmatched benefits, including flexibility, versatility, selectivity, and stability. These polymers can be customized for diverse substrate formats, effortlessly capture cell-free NAs from simple and complex solutions, prioritize rare cell-free NA fragments, and safeguard bound NAs at room temperature. With limitless capacity, BIOCAPTIVA processes sample volumes ranging from milliliters to liters, offering exceptional scalability. The primary address of BIOCAPTIVA LIMITED is Edinburgh, GB.

BIOCAPTIVA LIMITED is driving transformative advancements in biotechnology to unlock new horizons in genetic disease management and multi-omics research, shaping the future of precision medicine. We invite the manager of BIOCAPTIVA LIMITED to create a customized and exclusive company showcase and product listing on our platform to further enhance your company's visibility and commercial development.